M. Alpert Et Al. , "A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections," BMC Infectious Diseases , vol.12, 2012
Alpert, M. Et Al. 2012. A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections. BMC Infectious Diseases , vol.12 .
Alpert, M., Rahav, G., Rill, D., Zito, E., Gardiner, D., Pedersen, R., ... Babinchak, T.(2012). A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections. BMC Infectious Diseases , vol.12.
Alpert, Marc Et Al. "A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections," BMC Infectious Diseases , vol.12, 2012
Alpert, Marc Et Al. "A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections." BMC Infectious Diseases , vol.12, 2012
Alpert, M. Et Al. (2012) . "A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections." BMC Infectious Diseases , vol.12.
@article{article, author={Marc Alpert Et Al. }, title={A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections}, journal={BMC Infectious Diseases}, year=2012}